Ax-2 Mission Science on the Mission Press Conference: Axiom Space hosted a virtual press conference with the company’s in-space manufacturing and science team, the Saudi Space Commission, and select principal investigators representing the more than 20 different experiments that will be conducted during Axiom Mission 2 (Ax-2). During the press conference, leaders highlighted the science research, technology demonstrations, and in-space manufacturing projects that will occur on the mission, as well as touched upon Axiom Station and the future of in-space solutions. The speakers included:
Dr. Lucie Low, Chief Scientist, Axiom Space;
Jana Stoudemire, Director of In-Space Manufacturing, Axiom Space;
Mishaal Ashemimry, Microgravity Research Lead, Saudi Space Agency;
Mari Anne Snow, Chief Executive Office, Eascra Biotech;
Dr. Clive Svendsen, Executive Director of Regenerative Medicine Institute, Cedars-Sinai;
Dr. Catriona Jamieson, Director, Sanford Stem Cell Clinical Center at UC San Diego Health;
Dr. Anthony Atala, Director, Wake Forest Institute for Regenerative Medicine;
Dava Newman, Director, MIT Media Lab;
Ax-2 is now targeted to launch to the International Space Station NET May 8 at 10:43 p.m. EDT aboard a SpaceX Dragon spacecraft from Launch Complex 39A at NASA’s Kennedy Space Center in Florida.